Evangelio, Larry A.

HRN: 26-68-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/12/2025
MUPIROCIN 2%, 15G (TUBE)
02/12/2025
02/19/2025
TOPICAL
2%
BID
Multiple Abrasion
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: